(Q45127845)

English

High FDG uptake predicts poorer survival in locally advanced nonsmall cell lung cancer patients undergoing curative radiotherapy, independently of tumor size

scientific article published on 29 January 2014

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

High FDG uptake predicts poorer survival in locally advanced nonsmall cell lung cancer patients undergoing curative radiotherapy, independently of tumor size (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

author name string

Sukran Ulger

1

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Nilgun Yilmaz Demirci

2

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Fatma Nazan Eroglu

3

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Huriye Hulya Cengiz

4

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Mustafa Tunc

5

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Ebru Tatci

6

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Ulku Yilmaz

7

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Eren Cetin

8

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Emine Avci

9

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Mustafa Cengiz

10

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

publication date

29 January 2014

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Journal of Cancer Research and Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

140

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

495-502

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Overestimation of the prognostic significance of SUV measurement by positron emission tomography for non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1591-9

21 January 2018

Prognostic factors in non-small cell lung cancer: a decade of progress

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1591-9

21 January 2018

Comparison of [18F]fluorodeoxyglucose uptake with glucose transporter-1 expression and proliferation rate in human glioma and non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1591-9

21 January 2018

[(18)F]Fluorodeoxyglucose positron emission tomography and its prognostic value in lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1591-9

21 January 2018

Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1591-9

21 January 2018

Is standardised (18)F-FDG uptake value an outcome predictor in patients with stage III non-small cell lung cancer?

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1591-9

21 January 2018

Recovery correction for quantitation in emission tomography: a feasibility study

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1591-9

21 January 2018

Non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1591-9

21 January 2018

The Tumor Microenvironment in Non–Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1591-9

21 January 2018

Use of a corrected standardized uptake value based on the lesion size on CT permits accurate characterization of lung nodules on FDG-PET.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1591-9

21 January 2018

Predictive value of 18F-fluorodeoxyglucose uptake by positron emission tomography for non-small cell lung cancer patients treated with radical radiotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1591-9

21 January 2018

Application of machine learning methodology for PET-based definition of lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1591-9

21 January 2018

Hypoxic gene expression and metastasis

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1591-9

21 January 2018

High fluorodeoxyglucose uptake on positron emission tomography in patients with advanced non-small cell lung cancer on platinum-based combination chemotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1591-9

21 January 2018

Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1591-9

21 January 2018

[18F]FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1591-9

21 January 2018

Prognostic significance of p53, Ki-67, VEGF and Glut-1 in resected stage I adenocarcinoma of the lung

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1591-9

21 January 2018

FDG uptake, glucose transporter type 1, and Ki-67 expressions in non-small-cell lung cancer: correlations and prognostic values.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1591-9

21 January 2018

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1591-9

21 January 2018

Dose escalation for non-small cell lung cancer: analysis and modelling of published literature.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1591-9

21 January 2018

Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1591-9

21 January 2018

18F-FDG PET definition of gross tumor volume for radiotherapy of lung cancer: is the tumor uptake value-based approach appropriate for lymph node delineation?

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1591-9

21 January 2018

Fluorodeoxyglucose uptake of primary non-small cell lung cancer at positron emission tomography: new contrary data on prognostic role

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1591-9

21 January 2018

The unique physiology of solid tumors: opportunities (and problems) for cancer therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24474555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24474555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tracer feasibility for monitoring tumor radiotherapy: a quadruple tracer study with fluorine-18-fluorodeoxyglucose or fluorine-18-fluorodeoxyuridine, L-[methyl-14C]methionine, [6-3H]thymidine, and gallium-67

1 reference

https://pubmed.ncbi.nlm.nih.gov/24474555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A clinical evaluation of FDG-PET to assess the response in radiation therapy for bronchogenic carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24474555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/24474555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation of Glut-1 glucose transporter expression with [(18)F]FDG uptake in non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24474555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in non-small cell lung cancer assessed by 18F-Fluoromisonidazole and 18F-FDG PET.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24474555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between retention index in dual-phase (18)F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24474555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

https://pubmed.ncbi.nlm.nih.gov/24474555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The CT motion quantitation of lung lesions and its impact on PET-measured SUVs.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24474555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00432-014-1591-9

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45127845&oldid=2207110314"